Skip to main content
Equibles

STATE STREET CORP

Position in MLTX — MoonLake Immunotherapeutics

CIK 93751 BOSTON, MA
Back to MLTX Full portfolio

Position in MLTX

as of Jun 30, 2026 · filed Aug 7, 2026
Position Value
$1,697,122
+$644,149 QoQ
Shares Held
87,166
+54.3% QoQ
Ownership
0.102%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#72
of 172 holders
Holding Since
Sep 2023
12 quarters on record
Voting authority Sole 14% Shared 0% None 86%

Common Shares in MLTX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

STATE STREET CORP holds $36,881,619,425 across 411 Biotechnology names. MLTX ranks #274 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 11,871,459 $5,896,909,829
2 REGN
Regeneron Pharmaceuticals, Inc.
 4,834,688 $3,014,621,355
3 INCY
Incyte Corp
 9,722,336 $1,102,124,008
4 MRNA
Moderna, Inc.
 15,726,193 $1,101,305,295
5 ALNY
Alnylam Pharmaceuticals, Inc.
 3,555,689 $1,070,369,059
6 RVMD
Revolution Medicines, Inc.
 4,897,051 $917,119,711
7 RPRX
Royalty Pharma plc
 12,338,229 $691,804,500
8 INSM
INSMED Inc
 6,052,174 $645,282,791

All Filings in MLTX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,697,122 87,166
2026-03-31 $1,052,973 56,490
2025-12-31 $671,824 50,973
2025-09-30 $379,192 52,886
2025-06-30 $3,047,420 64,564
2025-03-31 $3,649,020 93,397
2024-12-31 $4,957,161 91,545
2024-09-30 $4,418,657 87,637
2024-06-30 $1,963,568 44,657
2024-03-31 $2,278,483 45,361
2023-12-31 $1,832,292 30,341
2023-09-30 $1,185,600 20,800